Physician profile
Elise E Steinberger
NPI 1710515242
$1,060.89
in general payments reported to CMS, 2019-2025
9 companies · $464 in 2025
The $464 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $138 · 2022: $17.73 · 2023: $381 · 2024: $60.99 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $905.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $905.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $353.95 | 2023-2025 | Clareon, Hydrus Microstent, Centurion |
| Biotissue Holdings INC. | $206.00 | 2025 | |
| Bausch & Lomb Americas INC. | $161.41 | 2022-2025 | Xiidra, Miebo, Stellaris |
| Merz Pharmaceuticals, LLC | $103.05 | 2023 | Xeomin |
| Allergan, INC. | $99.99 | 2021 | |
| New World Medical,INC. | $60.41 | 2023 | |
| Depuy Synthes Sales INC. | $37.99 | 2023 | Synpor |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.34 | 2021 | |
| Antares Pharma, INC. | $14.75 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elise Steinberger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.